Design Therapeutics Inc

History of Design Therapeutics Inc

Design Therapeutics Inc. was founded in 2017, by a team of experienced researchers and biotech executives. The company focuses on discovering and developing small molecule therapies for the treatment of serious degenerative diseases, such as Friedreich ataxia and other repeat expansion diseases.

Design Therapeutics has a unique approach to drug discovery that leverages a deep understanding of the molecular basis of these diseases. The company aims to target specific genetic mutations and RNA abnormalities that are at the root of the disease process.

Since its inception, Design Therapeutics has secured significant funding from venture capital firms and strategic partners, including Pfizer Ventures, Sanofi Ventures, and Belinda Gates-backed Pivotal Ventures. This funding has enabled the company to advance its drug candidate pipeline through preclinical development and towards clinical trials.

Design Therapeutics is headquartered in San Diego, California, and is led by an experienced management team with a track record of success in biotech and pharmaceutical development. The company is committed to improving the lives of patients affected by serious degenerative diseases through innovative drug discovery and development.